Literature DB >> 3070259

Surface exposure of the O-antigen in Klebsiella pneumoniae O1:K1 serotype strains.

J M Tomas1, S Camprubi, P Williams.   

Abstract

Isogenic non-encapsulated (K-) mutants (O1:K-) were obtained from several different Klebsiella pneumoniae O1:K1 serotype strains. By employing K. pneumoniae bacteriophages FC3-1, FC3-2, and bacteriophage phi 1, the bacterial surface receptors of which, are the O1-antigen of lipopolysaccharide and the K1 capsular polysaccharide (K1) respectively, the K1 polysaccharide was found to completely cover the O1 lipopolysaccharide molecules in each of the O1:K1 strains examined. Exposure of the O-antigen at the cell surface was only observed after growth in the presence of sub-minimum inhibitory concentrations of antibiotics. The implications of these findings for the design of vaccines for the prevention of Klebsiella infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3070259     DOI: 10.1016/0882-4010(88)90016-2

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Authors:  S Merino; S Camprubí; S Albertí; V J Benedí; J M Tomás
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Salicylate-enhanced exposure of Klebsiella pneumoniae subcapsular components.

Authors:  R J Salo; P Domenico; J M Tomás; D C Straus; S Merino; V J Benedí; B A Cunha
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

3.  Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae.

Authors:  Elizabeth Diago-Navarro; Isabel Calatayud-Baselga; Donglei Sun; Camille Khairallah; Inderjit Mann; Amaia Ulacia-Hernando; Brian Sheridan; Meiqing Shi; Bettina C Fries
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

4.  Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

Authors:  S Albertí; D Alvarez; S Merino; M T Casado; F Vivanco; J M Tomás; V J Benedí
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.

Authors:  T Rukavina; B Tícac; M Susa; N Jendrike; S Jonjíc; P Lucin; R Marre; M Doríc; M Trautmann
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens.

Authors:  J M Tomás; S Camprubi; S Merino; M R Davey; P Williams
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.

Authors:  Urban Lundberg; Beatrice M Senn; Wolfgang Schüler; Andreas Meinke; Markus Hanner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

Review 8.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

9.  Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide.

Authors:  P Domenico; J M Tomas; S Merino; X Rubires; B A Cunha
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 10.  Klebsiella: a long way to go towards understanding this enigmatic jet-setter.

Authors:  Christopher A Broberg; Michelle Palacios; Virginia L Miller
Journal:  F1000Prime Rep       Date:  2014-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.